Xilio Development
Price & Volume
Stats
See more52W Range | $0.61-$1.70 |
Market Cap | $47.6M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $31.8M |
Revenue Growth (YoY) | 742.5% |
Gross Profit (12 Mos) | $26.2M |
Diluted EPS | -$0.61 |
News
See moreYahoo Finance • 2 months ago
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
Yahoo Finance • 2 months ago
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
About
CEO | Dr. Rene Russo BCPS, Pharm.D. |
CFO | Mr. Christopher Frankenfield |
Address | 828 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 64 |
